Advertisement

ADVERTISEMENT

inflammatory bowel disease

News
Anti-TNF Therapy May Increase Risk for IBD
07/06/2017
Anti-tumor necrosis factor-α (anti-TNF-α) therapy is the most prescribed biologic therapy in rheumatology and gastroenterology. However, these therapies can cause serious side effects, including new-onset inflammatory bowel disease.
Anti-tumor necrosis factor-α (anti-TNF-α) therapy is the most prescribed biologic therapy in rheumatology and gastroenterology. However, these therapies can cause serious side effects, including new-onset inflammatory bowel disease.
Anti-tumor necrosis factor-α...
07/06/2017
Advances in Inflammatory Bowel Disease Network
News
Why Do Some IBD Patients Have Poor Response to Treatment?
06/12/2017
In this study, researchers assessed patients with inflammatory bowel disease to determine why some did not respond to anti-TNF agents or had lost response over time. To see which factors may be involved with non-response, read more.
In this study, researchers assessed patients with inflammatory bowel disease to determine why some did not respond to anti-TNF agents or had lost response over time. To see which factors may be involved with non-response, read more.
In this study, researchers...
06/12/2017
Advances in Inflammatory Bowel Disease Network
News
Antibiotic Combination Has Therapeutic Benefits for Patients With Early-Onset IBD
06/02/2017
Researchers assessed the efficacy of 2 oral antibiotics in young children with very early onset inflammatory bowel disease.
Researchers assessed the efficacy of 2 oral antibiotics in young children with very early onset inflammatory bowel disease.
Researchers assessed the...
06/02/2017
Advances in Inflammatory Bowel Disease Network
Transcript: Christina Y. Ha, MD, on Managing C difficile Infection in Patients With IBD
08/06/2010
Colleen Murphy: Hello, everyone, and welcome to another installment of “Podcast 360,” your go‑to resource for medical news and clinical updates. I’m your moderator, Colleen Murphy, with Consultant360 Specialty Network.
Colleen Murphy: Hello, everyone, and welcome to another installment of “Podcast 360,” your go‑to resource for medical news and clinical updates. I’m your moderator, Colleen Murphy, with Consultant360 Specialty Network.
Colleen Murphy: Hello, everyone,...
08/06/2010
Advances in Inflammatory Bowel Disease Network
Transcript: Raymond Cross, MD, on Precision Medicine and Companion Diagnostics
07/23/2010
Hi everyone, my name is Raymond Cross. I am a professor of medicine and director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine. I'd like to give a brief synopsis of my talk presented at the Chicago...
Hi everyone, my name is Raymond Cross. I am a professor of medicine and director of the Inflammatory Bowel Disease Program at the University of Maryland School of Medicine. I'd like to give a brief synopsis of my talk presented at the Chicago...
Hi everyone, my name is Raymond...
07/23/2010
Gastroenterology
Transcript: Aline Charabaty, MD, on Using Social Media in IBD Practice
07/17/2010
My name is Aline Charabaty. I'm the director of the IBD Center at Johns Hopkins Sibley Memorial Hospital in Washington, DC. My passion is IBD education, and during IBD Chicago I'll be sharing with you tips on how to use Twitter to learn,...
My name is Aline Charabaty. I'm the director of the IBD Center at Johns Hopkins Sibley Memorial Hospital in Washington, DC. My passion is IBD education, and during IBD Chicago I'll be sharing with you tips on how to use Twitter to learn,...
My name is Aline Charabaty. I'm...
07/17/2010
Advances in Inflammatory Bowel Disease Network
Videos
Corey Siegel, MD, on Positioning JAK Inhibitors in IBD Management
06/23/2010
In this video, Corey Siegel, MD, section chief of gastroenterology and hepatology at Dartmouth-Hitchcock Medical Center, previews his talk on positioning of JAK inhibitors and small molecules in treatment of IBD at the Advances in...
In this video, Corey Siegel, MD, section chief of gastroenterology and hepatology at Dartmouth-Hitchcock Medical Center, previews his talk on positioning of JAK inhibitors and small molecules in treatment of IBD at the Advances in...
In this video, Corey Siegel, MD,...
06/23/2010
Advances in Inflammatory Bowel Disease Network
Q&As
5 Questions About Managing IBD in Special Populations
06/11/2010
The lead authors of new publication on the challenges associated with inflammatory bowel disease, obesity, aging, and other comorbidities, and the special considerations for women who are or wish to become pregnant, answered our burning...
The lead authors of new publication on the challenges associated with inflammatory bowel disease, obesity, aging, and other comorbidities, and the special considerations for women who are or wish to become pregnant, answered our burning...
The lead authors of new...
06/11/2010
Advances in Inflammatory Bowel Disease Network

Advertisement

Advertisement

Advertisement

Advertisement

Upcoming Events

September 21 ⁠–⁠ September 22
AMP Europe
September 30 ⁠–⁠ October 2
October 1 ⁠–⁠ October 2
SAWC Fall
October 2 ⁠–⁠ October 5
October 5 ⁠–⁠ October 6
SMASH
October 14 ⁠–⁠ October 16
Lymphoma, Leukemia, and Myeloma
October 16 ⁠–⁠ October 19
October 19 ⁠–⁠ October 20
October 26 ⁠–⁠ October 27
October 29 ⁠–⁠ November 2
See Full Calendar

Advertisement

Advertisement

Advertisement

Specialties

Events

Year Round Education

HMP Global Products

HMP Education Logo
HMP Omnimedia Logo
HMP Europe Logo
© 2024 HMP Global. All Rights Reserved.
Privacy Policy Terms of Use